Cerebrospinal fluid exposure of cenicriviroc in HIV‐positive individuals with cognitive impairment

Lignende værker

• The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
  af: Amara, Alieu, et al.
  Udgivet: (2021)
• Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)
  af: Herrera, Carolina, et al.
  Udgivet: (2021)
• Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS
  af: Waitt, Catriona, et al.
  Udgivet: (2017)
• Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
  af: Scarsi, Kimberly, et al.
  Udgivet: (2014)
• Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis
  af: Nightingale, Sam, et al.
  Udgivet: (2016)